Aap Implantate Ag · XETR:AAQ1

Aap Implantate — Q1 2018 Earnings Presentation

8 slides from Aap Implantate's earnings presentation, May 14, 2018

  1. Slide 1: aap Implantate AG Q1/2018 Report Conference Call

    aap Implantate AG Q1/2018 Report Conference Call Bruke Seyoum Alemu, CEO Marek Hahn, CFO Berlin, May 14, 2018

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Our publication may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual

  3. Slide 3: Key results and progress Q1/2018

    Key results and progress Q1/2018 ➢ Sales and Earnings ▪ Sales (EUR 2.8 million) and EBITDA (EUR -1.6 million) on the upper end of the guidance ▪ Significant sales increase in international region (+32%) – growth drivers: expansion of business with existing customers and new customer business (includ

  4. Slide 4: Financial Figures Q1/2018

    Financial Figures Q1/2018 (in KEUR) Sales Q1/2018 Q1/2017 Change Trauma 2,797 2,901 -4% Germany 656 634 +3% North America 530 1,043 -49% North America Distributors 513 578 -11% North America Global Partners 18 465 -96% International 1,610 1,224 +32% Other (mainly discontinued activities) -15 194 -10

  5. Slide 5: Highlights Q1/2018 (Balance Sheet)

    Highlights Q1/2018 (Balance Sheet) • Total assets 03/31/2017: EUR 47.3 million (12/31/2017: EUR 50.5 million)  -6% ▪ Non-current assets: Change EUR -0.3 million  Capitalized development costs: EUR +0.2 million  Share of intangible assets in total assets: 25%  Healthy ratio  Tangible assets: EUR

  6. Slide 6: Highlights Q1/2018 (Cash Flow)

    Highlights Q1/2018 (Cash Flow) • Operating Cash Flow Q1/2018: EUR -1.4 million (Q1/2017: EUR -1.2 million) ▪ Positive contribution from working capital reduction of EUR 0.3 million ▪ Improved debtor management: trade receivables of EUR 2.4 million (FY/2017: EUR 2.5 million)  Further improved DSO to

  7. Slide 7: Outlook FY/2018

    Outlook FY/2018 Q2/2018 – Sales: EUR 1.8 million – EUR 3.0 million (Q2/2017: EUR 2.3 million) – EBITDA: EUR -1.9 million – EUR -1.4 million (Q2/2017: EUR -1.6 million) FY/2018 – Sales: EUR 13.0 million – EUR 15.0 million (FY/2017: EUR 10.9 million) – EBITDA: EUR -5.0 million – EUR -3.4 million (FY/2

  8. Slide 8: Many thanks for your attention!

    Many thanks for your attention! Lorenzweg 5 • 12099 Berlin • Germany Fabian Franke Manager Investor Relations Tel.: +49 30 750 19 – 134 Fax: +49 30 750 19 – 290 E-Mail: ir@aap.de IR-app: 8

aap Implantate — Q1 2018 Earnings Presentation on 6ix